UM

Browse/Search Results:  1-10 of 11 Help

Selected(0)Clear Items/Page:    Sort:
Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy Journal article
Dong, Lei, Zhu, Yini, Zhang, Haoge, Gao, Lin, Zhang, Zhiqi, Xu, Xiaoxuan, Ying, Leqian, Zhang, Lu, Li, Yue, Yun, Zhengcheng, Zhu, Danqi, Han, Chang, Xu, Tingting, Yang, Hui, Ju, Shenghong, Chen, Xiaoyuan, Zhang, Haijun, Xie, Jinbing. Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy[J]. Advanced Materials, 2024.
Authors:  Dong, Lei;  Zhu, Yini;  Zhang, Haoge;  Gao, Lin;  Zhang, Zhiqi; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:27.4/30.2 | Submit date:2024/10/10
Cxcl10  Glioblastoma  Il-2  Immune Checkpoint Inhibitors  Immunosuppressive Microenvironment  Low-frequency Focused Ultrasound  T-cell Exhaustion  
Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by reducing K63-specific ubiquitination Journal article
Ding Moyu, Ning Chengqing, Chen Shaoru, Yin Haoran, Xu Jing, WANG YING. Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by reducing K63-specific ubiquitination[J]. doi: 10.1111/bph.17320, 2024, 181(22), 1–18.
Authors:  Ding Moyu;  Ning Chengqing;  Chen Shaoru;  Yin Haoran;  Xu Jing; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:6.8/7.4 | Submit date:2024/10/06
Immunosuppressive Activity  Inflammasome-driven Disease  K63-linked Ubiquitination,  Nlrp3  Triptolide Derivative  Triptolidiol  
Ultrathin Cu-TCPP Nanosheet-Based Electrochemical Microsensor for Detecting the Immunosuppressive Drug Mycophenolic Acid Journal article
Deng, Mingshi, Jin, Wei, Yang, Wenjuan, Tian, Lingling, Gao, Xinghua, Wang, Xuefeng, Feng, Lingyan, Janyasupab, Metini, Zhou, Bingpu, Zhang, Yuan. Ultrathin Cu-TCPP Nanosheet-Based Electrochemical Microsensor for Detecting the Immunosuppressive Drug Mycophenolic Acid[J]. ACS Applied Nano Materials, 2023, 6(24), 22979-22988.
Authors:  Deng, Mingshi;  Jin, Wei;  Yang, Wenjuan;  Tian, Lingling;  Gao, Xinghua; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:5.3/5.4 | Submit date:2024/02/22
Catalytic Activity  Cu−tcpp  Electrochemical Microsensor  Immunosuppressive Drugs  Ultrathin Mofs  
Self-Degradable Nanogels Reshape Immunosuppressive Tumor Microenvironment via Drug Repurposing Strategy to Reactivate Cytotoxic CD8+ T Cells Journal article
Tian,Hao, Li,Wenxi, Wang,Guohao, Tian,Ye, Yan,Jie, Zhou,Songtao, Yu,Xinying, Li,Bei, Dai,Yunlu. Self-Degradable Nanogels Reshape Immunosuppressive Tumor Microenvironment via Drug Repurposing Strategy to Reactivate Cytotoxic CD8+ T Cells[J]. Advanced Science, 2023, 10(21).
Authors:  Tian,Hao;  Li,Wenxi;  Wang,Guohao;  Tian,Ye;  Yan,Jie; et al.
Favorite | TC[WOS]:6 TC[Scopus]:11  IF:14.3/16.3 | Submit date:2023/08/03
Cd8++++ t Cells  Drug Repurposing  Immunosuppressive Tumor Microenvironment  Self-degradable Nanogels  
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy Journal article
Lau, George, Yu, Ming Lung, Wong, Grace, Thompson, Alexander, Ghazinian, Hasmik, Hou, Jin Lin, Piratvisuth, Teerha, Jia, Ji Dong, Mizokami, Masashi, Cheng, Gregory, Chen, Guo Feng, Liu, Zhen Wen, Baatarkhuu, Oidov, Cheng, Ann Lii, Ng, Woon Leung, Lau, Patrick, Mok, Tony, Chang, Jer Ming, Hamid, Saeed, Dokmeci, A. Kadir, Gani, Rino A., Payawal, Diana A., Chow, Pierce, Park, Joong Won, Strasser, Simone I., Mohamed, Rosmawaiti, Win, Khin Maung, Tawesak, Tanwandee, Sarin, Shiv Kumar, Omata, Masao. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy[J]. Hepatology International, 2021, 15(5), 1031-1048.
Authors:  Lau, George;  Yu, Ming Lung;  Wong, Grace;  Thompson, Alexander;  Ghazinian, Hasmik; et al.
Favorite | TC[WOS]:72 TC[Scopus]:79  IF:5.9/6.6 | Submit date:2021/12/08
Apasl  Guideline  Hepatitis b Reactivation  Immunosuppressive Therapy  
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy Review article
2020
Authors:  Zhu,Yuefei;  Yu,Xiangrong;  Thamphiwatana,Soracha D.;  Zheng,Ying;  Pang,Zhiqing
Favorite | TC[WOS]:66 TC[Scopus]:72  IF:14.7/14.1 | Submit date:2021/03/01
Cancer Immunotherapy  Drug Delivery  Nanomedicine  Tumor Immunosuppressive Microenvironment  
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor: An Opportunity for Cancer Treatment Journal article
Mohammad, A., Engku Nur, S., Jennifer, B., Khalid, F., Jean-Luc, S., Chen, X., Eyad, E., Magdalena, P., Rohimah, M.. Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor: An Opportunity for Cancer Treatment[J]. Cells, 2019, 9(1), 33.
Authors:  Mohammad, A.;  Engku Nur, S.;  Jennifer, B.;  Khalid, F.;  Jean-Luc, S.; et al.
Favorite | TC[WOS]:16 TC[Scopus]:15  IF:4.5/4.9 | Submit date:2022/08/30
Immunosuppressive  Immunotherapy  Nanoparticles  Regulatory t Cells  Tnf  
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment Journal article
Al-Hatamleh,Mohammad A.I., E A R,Engku Nur Syafirah, Boer,Jennifer C., Ferji,Khalid, Six,Jean Luc, Chen,Xin, Elkord,Eyad, Plebanski,Magdalena, Mohamud,Rohimah. Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment[J]. Cells, 2019, 9(1), 33.
Authors:  Al-Hatamleh,Mohammad A.I.;  E A R,Engku Nur Syafirah;  Boer,Jennifer C.;  Ferji,Khalid;  Six,Jean Luc; et al.
Favorite | TC[WOS]:16 TC[Scopus]:15  IF:5.1/6.0 | Submit date:2021/03/01
Immunosuppressive  Immunotherapy  Nanoparticles  Regulatory t Cells  Tnf  
Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells (review) Journal article
Chen, X., Oppenheim, J.. Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells (review)[J]. International Immunopharmacology, 2011, 1489-1496.
Authors:  Chen, X.;  Oppenheim, J.
Favorite |   IF:4.8/5.0 | Submit date:2022/08/30
Regulatory T cells  Cellular markers  Immunosuppressive function  
Five new C21 steroidal glycosides from Periploca sepium Journal article
Wang L., Yin Z.-Q., Zhang Q.-W., Zhang X.-Q., Zhang D.-M., Liu K., Li Y.-L., Yao X.-S., Ye W.-C.. Five new C21 steroidal glycosides from Periploca sepium[J]. Steroids, 2011, 76(3), 238-243.
Authors:  Wang L.;  Yin Z.-Q.;  Zhang Q.-W.;  Zhang X.-Q.;  Zhang D.-M.; et al.
Favorite | TC[WOS]:20 TC[Scopus]:26  IF:2.1/2.4 | Submit date:2018/10/30
Asclepiadaceae  C21 Steroidal Glycoside  Immunosuppressive Activity  Periploca Sepium  Periseosides A-e